2015
DOI: 10.1002/wnan.1334
|View full text |Cite
|
Sign up to set email alerts
|

Improving drug biological effects by encapsulation into polymeric nanocapsules

Abstract: This review is based on selected reports from 2004 to 2014 and provides a comprehensive and updated overview of the state of the art related to the drug delivery advantages of polymeric nanocapsules, which are a specific type of polymeric nanoparticles used for improvement of biological effects. Special attention is given to the application of nanocapsules to increase the chemical and photostability of drugs, to modulate the interaction with cells and tissues, to reduce adverse effects of drugs, and to increas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
46
0
4

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 125 publications
(50 citation statements)
references
References 76 publications
0
46
0
4
Order By: Relevance
“…The use of submicrometric colloidal nanocarriers such as nanoparticles (NP) lipid and polymeric, nanoemulsions (NE), microemulsions (ME), liposomes, and polymeric micelles is considered a promising system in the pharmaceutical field, because they have numerous advantages over traditional formulations such as: sustained release of the active element; solubilization of lipophilic molecules; use for different routes of administration; protection from chemical and enzymatic degradation of labile molecules; reduction of vegetable oils (VO) volatilization, side effects and dose (Mäder, Mehnert, 2005;Mehnert, Mäder, 2001;Gref, Couvreour, 2006;Couvreur, Vauthier, 2006;Panyam, Labhasetwar, 2003;Soppimath et al, 2001;Ai et al, 2011;Contri et al, 2012;Contri et al, 2014;Dimer et al, 2014;Severino et al, 2015;Frank et al, 2015;Asbahani et al, 2015). However, all systems differ thermodynamic stability, structure, chemical composition, efficiency encapsulation and types of application (Mäder, Mehnert, 2005;Ai et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…The use of submicrometric colloidal nanocarriers such as nanoparticles (NP) lipid and polymeric, nanoemulsions (NE), microemulsions (ME), liposomes, and polymeric micelles is considered a promising system in the pharmaceutical field, because they have numerous advantages over traditional formulations such as: sustained release of the active element; solubilization of lipophilic molecules; use for different routes of administration; protection from chemical and enzymatic degradation of labile molecules; reduction of vegetable oils (VO) volatilization, side effects and dose (Mäder, Mehnert, 2005;Mehnert, Mäder, 2001;Gref, Couvreour, 2006;Couvreur, Vauthier, 2006;Panyam, Labhasetwar, 2003;Soppimath et al, 2001;Ai et al, 2011;Contri et al, 2012;Contri et al, 2014;Dimer et al, 2014;Severino et al, 2015;Frank et al, 2015;Asbahani et al, 2015). However, all systems differ thermodynamic stability, structure, chemical composition, efficiency encapsulation and types of application (Mäder, Mehnert, 2005;Ai et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…8,9 Different drug-delivering systems such as liposomes, [10][11][12][13] dendrimers, 14,15 polymersomes, 16,17 and carbon-based nanoparticles 18,19 have been tested, but until now, only liposomes and albumin nanoparticles containing anticancer drugs have been used clinically. [20][21][22] Polymeric nanocarriers such as multifunctional lipidcoated nanoparticles 23 and polymeric nanocapsules 24 have encouraging therapeutic applications of nanodrug delivery systems, especially as carriers for anticancer drugs into solid tumors. Those effects are due to excellent endocytosis, passive tumor targeting, high encapsulation efficiency, and high stability of polymeric nanoparticles, allowing for extended time in the circulatory system.…”
Section: Introductionmentioning
confidence: 99%
“…Those effects are due to excellent endocytosis, passive tumor targeting, high encapsulation efficiency, and high stability of polymeric nanoparticles, allowing for extended time in the circulatory system. 24 Our research group developed a hybrid biodegradable nanoparticle called lipid-core nanocapsules (LNCs) that are core-shell structures consisting of a lipid core, composed of sorbitan monostearate (SM) dispersed in capric/caprylic triglyceride (CCT), surrounded by a poly(ε-caprolactone) (PCL) wall, and stabilized by polysorbate 80 micelles at the particle/water interface. 25 Several studies have shown the effectiveness of LNC in carrying different drugs to treat cancer and inflammatory diseases.…”
Section: Introductionmentioning
confidence: 99%
“…7 To solve this limitation, a large number of studies have been published describing new delivery systems such as inclusion complexes with cyclodextrins [8][9][10][11] and nanoparticles. 7,[12][13][14][15] Nanoparticle systems have been considered promising carriers of therapeutic drugs, and the application of these particles as carriers of natural compounds has been extensively studied over the past few years. 16 One of the main challenges in relation to chronic diseases is patient adherence to prescribed treatments.…”
mentioning
confidence: 99%
“…18 Several studies have evaluated the administration of nanocapsules by different routes, namely oral, ocular, cutaneous, vaginal and parenteral, demonstrating the versatility of the systems. 12 Lipid-core nanocapsules (LNCs) are a very specific kind of nontoxic polymeric nanocapsules, 14 in which the oily core is formed by an organogel composed of capric/caprylic triglyceride and sorbitan monostearate. The core chemical composition allows these nanocapsules to control drug penetration in different tissues.…”
mentioning
confidence: 99%